SYK
68
4
SWKS
51
-2
CVS
52
-6
HOG
36
-3
ADBE
61
11
DUK
64
7
VMC
60
-2
BWA
48
-5
KLAC
53
-3
AZO
53
3
MAT
41
-4
UAL
83
-2
FOXA
53
3
PNW
70
3
MLM
58
-2
NWL
54
-3
MHK
50
-5
MU
36
-6
BF.B
33
-4
AKAM
50
-3
SYK
68
4
SWKS
51
-2
CVS
52
-6
HOG
36
-3
ADBE
61
11
DUK
64
7
VMC
60
-2
BWA
48
-5
KLAC
53
-3
AZO
53
3
MAT
41
-4
UAL
83
-2
FOXA
53
3
PNW
70
3
MLM
58
-2
NWL
54
-3
MHK
50
-5
MU
36
-6
BF.B
33
-4
AKAM
50
-3
Financhill
Back

Autolus Therapeutics PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

AUTL
Autolus Therapeutics PLC

Last Price:
3.31
Seasonality Move:
-10.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Autolus Therapeutics PLC Price Quote

$3.31
+0.22 (+6.95%)
(Updated: November 27, 2024 at 2:55 PM ET)

Autolus Therapeutics PLC Key Stats

Sell
50
Autolus Therapeutics PLC (AUTL) is a Sell
Day range:
$2.99 - $3.27
52-week range:
$2.69 - $7.45
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.73%
Volume:
1.8M
Avg. volume:
2.2M
1-year change:
-35.52%
Market cap:
$823.6M
Revenue:
$1.7M
EPS:
$-1.22

How Much Does Autolus Therapeutics PLC Make?

Data Unavailable

Is Autolus Therapeutics PLC Growing As A Company?

Data Unavailable

Autolus Therapeutics PLC Stock Price Performance

What Is Autolus Therapeutics PLC 52-Week High & Low?

Autolus Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Autolus Therapeutics PLC?

Is Autolus Therapeutics PLC Cash Flow Positive?

  • What Is AUTL Cash Flow From Operations?
    Cash flow from operations (TTM) is -$193.2M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $559.6M
  • What Is Autolus Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$12.4M

Autolus Therapeutics PLC Return On Invested Capital

Data Unavailable

Autolus Therapeutics PLC Earnings Date & Stock Price

Autolus Therapeutics PLC Competitors

Autolus Therapeutics PLC Dividend Yield

Autolus Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -41.99%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 10.45
Upside from Last Price: 237.64%

Major Shareholders

  • How many AUTL shares are owned by institutional investors?
    209M AUTL shares are owned by institutional investors
  • How many AUTL shares are owned by insiders?
    0 AUTL shares are owned by insiders